Key use cases for artificial intelligence to reduce the frequency of adverse drug events: a scoping review by Ania Syrowatka, PhD, Wenyu Song, PhD, Mary G Amato, PharmD, Dinah Foer, MD, Heba Edrees, PharmD, Zoe Co, BS, Masha Kuznetsova, MPH, Sevan Dulgarian, BS, Diane L Seger, RPh, Aurélien Simona, MD, Paul A Bain, PhD, Gretchen Purcell Jackson, MD, Kyu Rhee, MD, David W Bates, ProfMD

Get full text

Comprehensive Pharmacist-led Transitions-of-care Medication Management around Hospital Discharge Adds Modest Cost Relative to Usual Care: Time-and-Motion Cost Analysis by Teryl K. Nuckols MD, MSHS, Carl T. Berdahl MD, MS, Andrew J. Henreid MPH, Jeffrey L. Schnipper MD, MPH, Asad Rauf MD, EunJi M. Ko PharmD, An T. Nguyen OTD, Zoe Co BS, John Fanikos RPh, MBA, Ji-Hyun Kim PharmD, Donna W. Leang PharmD, Lina Matta PharmD, MPH, Kathleen Mulligan BA, Avik Ray MD, MS, Rita Shane PharmD, Kirollos Wassef PharmD, Joshua M. Pevnick MD, MSHS

Get full text